Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Headlines

    Italy moves to tighten controls on gender-affirming medical care for minors

    Italy moves to tighten controls on gender-affirming medical care for minors

    Published by Global Banking and Finance Review

    Posted on August 5, 2025

    Featured image for article about Headlines

    By Alvise Armellini

    ROME (Reuters) -Italy will tighten controls on the supply of gender-affirming medical care for minors, according to a draft law approved by the government that has triggered protests from transgender rights advocates.

    The law, passed by the cabinet late on Monday but still subject to parliamentary approval, will regulate medicines such as puberty blockers and feminising or masculinising hormones for those under the age of 18 who are experiencing gender dysphoria.

    In a statement, the government said it was needed "to protect the health of minors" and introduce "effective data monitoring."

    Gender dysphoria is the clinical diagnosis of significant distress that can result from an incongruence between a person's gender identity and their assigned sex at birth.

    The new bill states that gender-affirming medicines will only be dispensed following protocols yet to be drafted by the health ministry, and, pending that, after approval by a national ethics committee of paediatricians.

    It also sets up a national registry at the Italian Medicines Agency to monitor "the correct use of (these) medicines" and collect the detailed medical histories of each transgender person undergoing treatment.

    "This is a form of profiling of trans people, with all their sensitive data, in the hands of a government-nominated agency ... it is extremely serious," Roberta Parigiani, a spokesperson for the Trans Identity Movement, told Reuters on Tuesday.

    She said that introducing more layers of screening for the approval of gender-affirming medical care was concerning, as it increases the risk that treatment may be delayed for young teenagers or pre-teens waiting for it.

    "It's not like you can wait one or two years," Parigiani said.

    Under Prime Minister Giorgia Meloni, a self-described enemy of what she and her allies call the "LGTB lobby" and "gender ideology," Italy has a right-wing government that espouses so-called traditional family values.

    In the nearly three years that it has been in office, Meloni's coalition has made it harder for same-sex couples with children to be both recognised as legal parents, and has made it illegal for any couple to go abroad to have a baby via surrogacy.

    The draft bill could be rejected or substantially amended by parliament, but given that Meloni's coalition has a solid majority and backs its objectives, there is a high chance it will be approved.

    (Reporting by Alvise Armellini, Editing by Bernadette Baum)

    Related Posts
    Britain records new wind power generation record, NESO saysBritain records new wind power generation record, NESO says
    ECB criticises Italy's revised proposal on gold reserves, worries about central bank independenceECB criticises Italy's revised proposal on gold reserves, worries about central bank independence
    Trump calls EU fine on X 'nasty one', says Europe going in 'bad directions'Trump calls EU fine on X 'nasty one', says Europe going in 'bad directions'

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe